retatrutide triple agonist glp-1 gip glucagon receptor Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight What GLP‑3 Really Is: Retatrutide

Morton RW, Murphy KT, McKellar SR, et al

10.1016/j.ajo.2024.08.030

The Medicare GLP-1 Bridge will provide coverage of three GLP-1s (Wegovy, Zepbound, and Foundayo) that have been approved by the FDA for chronic weight management in adults with obesity (BMI of 30 or more) or adults with overweight (BMI of 27 or more) plus a weight-related comorbid condition

Mansur is conducting a larger trial with a placebo comparator group to further examine liraglutides effect on cognition in people with depression

Similarly, outcomes were consistent when comparing patients who used both GLP-1 RAs and SGLT2 is with those who did not receive either medication within the first 3 months post-transplant (Supplemental Table 10)

What arrives in a research peptide vial from an online vendor is a completely different question